Plunkett Research Online: Advaxis Inc

ADVAXIS INC (ADXS:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Advaxis Inc. is a biotechnology company utilizing multiple mechanisms of immunity with the intent to develop cancer vaccines that are more effective and safer than existing vaccines. The Company believes that by using its licensed Listeria System to engineer a live attenuated Listeria monocytogenes.....



Advaxis Inc
Ticker: ADXS
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 609 452-9813
Fax:
Address: 305 College Road East
Princeton, NJ 8540 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals
Cancer Vaccines
Contacts Description

Molly Henderson CFO/Chief Accounting Officer/Executive VP
Andres Gutierrez Chief Medical Officer/Executive VP
See More
Advaxis Inc. is a biotechnology company utilizing multiple mechanisms of immunity with the intent to develop cancer vaccines that are more effective and safer than existing vaccines. The Company believes that by using its licensed Listeria System to engineer a live attenuated Listeria monocytogenes.....See More See More

Auditor: Marcum LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2019 2018 2017 2016 2015 2014
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Name Title Salary (US$) Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: